MIT Researchers Reprogram NK Cells to Combat Cancer and Autoimmune Diseases

Researchers at MIT have devised a novel method to reprogram natural killer (NK) immune cells directly within the body using engineered nanoparticles. This innovative approach demonstrates potential in treating diseases driven by dysfunctional T cells, including lymphoma and autoimmune hepatitis. The technique could simplify therapeutic processes and reduce treatment costs for these conditions.